Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pelthos Therapeutics (PTHS) Shares Outstanding (Diluted Average) (2024 - 2025)

Pelthos Therapeutics has reported Shares Outstanding (Diluted Average) over the past 2 years, most recently at $1.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $1.9 million for Q4 2025, up 237.34% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (up 237.34% YoY), and the annual figure for FY2025 was $1.9 million, up 237.34%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $1.9 million at Pelthos Therapeutics, down from $3.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for PTHS hit a ceiling of $6.1 million in Q1 2025 and a floor of $523235.0 in Q2 2024.